These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 39116350)

  • 1. Histone deacetylase expression following cisplatin-induced acute kidney injury in male and female mice.
    Nguyen H; Gales A; Monteiro-Pai S; Oliver AS; Harris N; Montgomery AD; Franzén S; Kasztan M; Hyndman KA
    Am J Physiol Renal Physiol; 2024 Oct; 327(4):F623-F636. PubMed ID: 39116350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic changes in histone deacetylases following kidney ischemia-reperfusion injury are critical for promoting proximal tubule proliferation.
    Hyndman KA; Kasztan M; Mendoza LD; Monteiro-Pai S
    Am J Physiol Renal Physiol; 2019 May; 316(5):F875-F888. PubMed ID: 30810062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-Methylquinazoline derivative 23BB as a highly selective histone deacetylase 6 inhibitor alleviated cisplatin-induced acute kidney injury.
    Hao Y; Guo F; Huang Z; Feng Y; Xia Z; Liu J; Li L; Huang R; Lin L; Ma L; Fu P
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31894849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase–mediated silencing of AMWAP expression contributes to cisplatin nephrotoxicity.
    Ranganathan P; Hamad R; Mohamed R; Jayakumar C; Muthusamy T; Ramesh G
    Kidney Int; 2016 Feb; 89(2):317-26. PubMed ID: 26509586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin system expression in the kidney following cisplatin-induced acute kidney injury in male and female mice.
    Gales A; Monteiro-Pai S; Hyndman KA
    Can J Physiol Pharmacol; 2022 Sep; 100(9):868-879. PubMed ID: 35704945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone Deacetylases in Kidney Physiology and Acute Kidney Injury.
    Hyndman KA
    Semin Nephrol; 2020 Mar; 40(2):138-147. PubMed ID: 32303277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of HDAC6 protects against rhabdomyolysis-induced acute kidney injury.
    Shi Y; Xu L; Tang J; Fang L; Ma S; Ma X; Nie J; Pi X; Qiu A; Zhuang S; Liu N
    Am J Physiol Renal Physiol; 2017 Mar; 312(3):F502-F515. PubMed ID: 28052874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel PHD2/HDACs hybrid inhibitors protect against cisplatin-induced acute kidney injury.
    Wei H; Gou W; Gao J; Ning H; Song Y; Li D; Qin Y; Hou W; Li Y
    Eur J Med Chem; 2022 Feb; 230():114115. PubMed ID: 35033824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone Deacetylases Cooperate with NF-κB to Support the Immediate Migratory Response after Zebrafish Pronephros Injury.
    Zhuang M; Scholz A; Walz G; Yakulov TA
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Class IIa HDAC inhibitor TMP195 alleviates lipopolysaccharide-induced acute kidney injury.
    Zhang W; Guan Y; Bayliss G; Zhuang S
    Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1015-F1026. PubMed ID: 33017186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of HDAC8 mitigates AKI by reducing DNA damage and promoting homologous recombination repair.
    Wang Y; Yu C; Yu J; Shen F; Du X; Liu N; Zhuang S
    J Cell Mol Med; 2024 Sep; 28(18):e70114. PubMed ID: 39317961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-33 deficiency slows cancer growth but does not protect against cisplatin-induced AKI in mice with cancer.
    Ravichandran K; Holditch S; Brown CN; Wang Q; Ozkok A; Weiser-Evans MC; Nemenoff R; Miyazaki M; Thiessen-Philbrook H; Parikh CR; Ljubanovic D; Edelstein CL
    Am J Physiol Renal Physiol; 2018 Mar; 314(3):F356-F366. PubMed ID: 29070568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc-dependent histone deacetylases: Potential therapeutic targets for arterial hypertension.
    Kee HJ; Kim I; Jeong MH
    Biochem Pharmacol; 2022 Aug; 202():115111. PubMed ID: 35640713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease.
    Jia H; Pallos J; Jacques V; Lau A; Tang B; Cooper A; Syed A; Purcell J; Chen Y; Sharma S; Sangrey GR; Darnell SB; Plasterer H; Sadri-Vakili G; Gottesfeld JM; Thompson LM; Rusche JR; Marsh JL; Thomas EA
    Neurobiol Dis; 2012 May; 46(2):351-61. PubMed ID: 22590724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of histone deacetylation with vorinostat does not prevent tunicamycin-mediated acute kidney injury.
    Carlisle RE; Farooqi S; Zhang MC; Liu S; Lu C; Phan A; Brimble E; Dickhout JG
    PLoS One; 2021; 16(11):e0260519. PubMed ID: 34847196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of BMP-7 by histone deacetylase 2 promoted apoptosis of renal tubular epithelial cells in acute kidney injury.
    Ma T; Huang C; Xu Q; Yang Y; Liu Y; Meng X; Li J; Ye M; Liang H
    Cell Death Dis; 2017 Oct; 8(10):e3139. PubMed ID: 29072686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential Effects of HDAC6 Inhibition Versus Knockout During Hepatic Ischemia-Reperfusion Injury Highlight Importance of HDAC6 C-terminal Zinc-finger Ubiquitin-binding Domain.
    Concors SJ; Hernandez PT; O'Brien C; DePaolo J; Murken DR; Aufhauser DD; Wang Z; Xiong Y; Krumeich L; Ge G; Beier UH; Bhatti TR; Kozikowski AP; Avelar LAA; Kurz T; Hancock WW; Levine MH
    Transplantation; 2024 Oct; 108(10):2084-2092. PubMed ID: 38685198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone Deacetylases Contribute to Excitotoxicity-Triggered Degeneration of Retinal Ganglion Cells In Vivo.
    Schlüter A; Aksan B; Fioravanti R; Valente S; Mai A; Mauceri D
    Mol Neurobiol; 2019 Dec; 56(12):8018-8034. PubMed ID: 31161423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PSTPIP2 inhibits cisplatin-induced acute kidney injury by suppressing apoptosis of renal tubular epithelial cells.
    Zhu H; Jiang W; Zhao H; He C; Tang X; Xu S; Xu C; Feng R; Li J; Ma T; Huang C
    Cell Death Dis; 2020 Dec; 11(12):1057. PubMed ID: 33311489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDAC9 is an epigenetic repressor of kidney angiotensinogen establishing a sex difference.
    Bourgeois CT; Satou R; Prieto MC
    Biol Sex Differ; 2017; 8():18. PubMed ID: 28572913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.